YUAN LiuFeng. Antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae in China, 2008: an epidemiological study[J].Chinese Journal of Dermatology, 2011, 44(7): 472-475.
[1] 叶顺章. 淋病实验室诊断//叶顺章,王千秋,王何英,等.性传播疾病的实验室诊断.2版.北京:科学出版社,2009:95-97. [2] World Health Organization.Sensitivity testing of Neisseria gonorrhoeae:methodologies for use by participants in the WHO Western Pacific Regional Resistance Surveillance Programme In:WHO / WPR Regional Antimicrobial Surveillance Working Group Meeting Proceedings,1992:33. [3] de Vries HJ, van der Helm JJ, Schim van der Loeff MF,et.al. Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands. Euro Surveill. 2009, 17;14(37). pii: 19330. [4] Australian Gonococcal Surveillance Programme, Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 2008. Commun Dis Intell. 2009, 33(3):268-274. [5] Templeton DJ, Jin F, McNally LP, et al, Kaldor JM, Kippax S, Grulich AE. Prevalence, incidence and risk factors for pharyngeal gonorrhoea in a community-based HIV-negative cohort of homosexual men in Sydney, Australia. Sex Transm Infect. 2010,86(2):90-96. [6] Bignell C; IUSTI/WHO. 2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2009,20(7):453-457. [7] 朱邦勇,李伟,黄培勇,等. 淋球菌耐药监测的流行病学研究. 中国麻风皮肤病杂志2009,25(1):32-34 [8] http://zhidao.baidu.com/question/26086332.html